反相高效液相色谱法同时测定决明子中芦荟大黄素和大黄素

用反相高效液相色谱法分离并测定了决明子中芦荟大黄素和大黄素，建立了该中药中芦荟大黄素、大黄素分离、测定的色谱方法。色谱条件：ＯＤＳ柱，甲醇－水（８０∶２０Ｖ／Ｖ）为流动相，检测波长２２３ｎｍ。本研究为决明子的质量评价提供了科学依据。     

Divergent and Overlapping Roles for Selected Phytochemicals in the Regulation of Pathological Cardiac Hypertrophy

Plant-based foods, like fruits, vegetables, whole grains, legumes, nuts, seeds and other foodstuffs, have been deemed as heart healthy. The chemicals within these plant-based foods, i.e., phytochemicals, are credited with protecting the heart. However, the mechanistic actions of phytochemicals, which prevent clinical endpoints, such as pathological cardiac hypertrophy, are still being elucidated. We sought to characterize the overlapping and divergent mechanisms by which 18 selected phytochemicals prevent phenylephrine- and phorbol 12-myristate 13-acetate-mediated cardiomyocyte enlargement. Of the tested 18 compounds, six attenuated PE- and PMA-mediated enlargement of neonatal rat ventricular myocytes. Cell viability assays showed that apigenin, baicalein, berberine hydrochloride, emodin, luteolin and quercetin dihydrate did not reduce cell size through cytotoxicity. Four of the six phytochemicals, apigenin, baicalein, berberine hydrochloride and emodin, robustly inhibited stress-induced hypertrophy and were analyzed further against intracellular signaling and genome-wide changes in mRNA expression. The four phytochemicals differentially regulated mitogen-activated protein kinases and protein kinase D. RNA-sequencing further showed divergence in gene regulation, while pathway analysis demonstrated overlap in the regulation of inflammatory pathways. Combined, this study provided a comprehensive analysis of cardioprotective phytochemicals. These data highlight two defining observations: (1) that these compounds predominantly target divergent gene pathways within cardiac myocytes and (2) that regulation of overlapping signaling and gene pathways may be of particular importance for the anti-hypertrophic actions of these phytochemicals. Despite these new findings, future works investigating rodent models of heart failure are still needed to understand the roles for these compounds in the heart.     

Analysis of the pharmacokinetics and metabolism of aloe‐emodin following intravenous and oral administrations in rats

Aloe‐emodin, a natural polyphenolic anthraquinone, has shown various beneficial bioactivities in vitro. The aim of this study was to investigate the pharmacokinetics and metabolism of aloe‐emodin. Aloe‐emodin was intravenously and orally administered to rats. The concentrations of aloe‐emodin and rhein, a metabolite of aloe‐emodin, were determined by HPLC method prior to and after hydrolysis with β‐glucuronidase and sulfatase/β‐glucuronidase. The results showed that the systemic exposures of aloe‐emodin and its metabolites were ranked as aloe‐emodin glucuronides (G) > rhein sulfates (S) > aloe‐emodin > rhein and rhein G when aloe‐emodin was given intravenously. In contrast, when aloe‐emodin was administered orally, the parent form of aloe‐emodin was not absorbed per se, and the systemic exposures of its metabolites were ranked as aloe‐emodin G > rhein G > rhein. In conclusion, the metabolites of aloe‐emodin are more important than the parent form for the bioactivities in vivo. Copyright © 2016 John Wiley & Sons, Ltd.     

Electrochemical Behavior of Herbal Antitumor Drug Aloe‐Emodin at Carbon‐Coated Nickel Magnetic Nanoparticles Modified Glassy Carbon Electrode

The electrochemical behavior of aloe‐emodin (AE), an important herbal antitumor drug, was investigated at a carbon‐coated nickel magnetic nanoparticles modified glassy carbon electrode (CNN/GCE). A couple of well‐defined redox peaks was obtained. Some electrochemical parameters of AE at a CNN/GCE, such as the charge number, exchange current density, standard heterogeneous rate constant, were measured. The square wave voltammetry (SWV) response of AE was linear with the concentration over two concentration intervals viz. 6.24×10^?9?1.13×10^?6 M and 1.13×10^?6?1.23×10^?5 M, with a detection limit of 2.08 nM. A fast, simple and sensitive detection and analysis of AE was developed.     

蒽醌类亲脂性阳离子的合成及抗癌活性

合成了7个大黄素季铵盐、2个芦荟大黄素季铵盐、1个水溶性大黄素季铵盐和1个α-萘酚醌苯基甲烷季铵盐化合物,并测试了其抗癌活性.含有1条长碳链的大黄素季铵盐的抗癌活性很低,但是含有2条长碳链的大黄素和芦荟大黄素季铵盐的抗癌活性较好.用亲水性的长链替代季铵盐中亲脂性的长碳链会导致大黄素季铵盐失去抗癌活性.α-萘酚醌苯基甲烷季铵盐显示了中等的抗癌活性,表明在具有电子传递能力的分子中引入亲脂性的长碳链季铵盐可以增加其抗癌活性.     

大黄素与DNA相互作用方式的研究

通过分子荧光分析、紫外可见吸收光谱及粘度分析以及与溴化乙锭的竞争性实验对大黄素与DNA之问的作用模式进行了考察.在pH 7.4,低离子强度(30 mmol/L NaCl)及恒温37℃条件下反应35 min,大黄素的荧光强度随DNA加入浓度的增加而递减,紫外可见吸收光谱在380、475 nm处出现等吸收点并红移5nm,表...     

基于中空纤维液相微萃取的大鼠体内大黄素及其代谢物分析

建立了中空纤维液相微萃取(HFLPME)耦合高效液相色谱法(HPLC)用于测定血浆和尿液中大黄素及其代谢物的浓度,比较了中药有效成分大黄素在不同性别大鼠体内的吸收和代谢能力,阐述了大黄素在体内的代谢和转化过程。本实验以聚偏氟乙烯纤维为溶剂载体,正辛醇为萃取溶剂,对血浆和尿液样品进行HFLPME处理,萃取后挥干有机溶剂,用50 μL甲醇溶解,进行HPLC测定。在优化的微萃取条件下,血浆和尿液样品中大黄素及其代谢物标准曲线线性良好(相关系数(r)大于0.9960);检出限为0.1～3.0 μg/L;富集倍数为12.2～26.3;日内、日间精密度(以相对标准偏差(RSD)计)小于11.0%;血浆和尿液中代谢物的平均回收率为97.9%～103%。HFLPME操作简单,富集倍数高,能有效去除生物样品中复杂基体的干扰,适用于复杂样品中微量、痕量成分分析物的分析测定。     

大黄素脂质体对Hep-2细胞毒的检测

采用逆相蒸发法制备了大黄素脂质体,测定了脂质体的包封率和粒径.通过苔盼蓝拒染法检测脂质体对Hep-2细胞的剂量和时间效应,初步研究了脂质体对Hep-2细胞的毒性,并根据加入脂质体后Hep-2细胞一周内的生长情况制作了生长曲线.结果测得由该法制备的大黄素脂质体平均包封率高达90.6%,透射电镜下观察到脂质体呈椭圆囊状结构,粒径分布均匀,其平均粒径分布在0.02~0.1μm之间,为单室脂质体.细胞毒实验表明大黄素脂质体对Hep-2细胞存在明显的细胞毒作用,且具有剂量和时间效应,随着脂质体中大黄素浓度从0.48mg.L-1增加到14.48 mg.L-1,死细胞百分率由23.15%增至94.5%,并测得脂质体对Hep-2细胞48 h的半数抑制浓度IC50为4.43 mg.L-1,浓度为7.24 mg.L-1的脂质体与Hep-2细胞作用12 h后,死细胞百分率增加到95%以上,加脂质体的Hep-2细胞生长曲线与没有加脂质体的正常Hep-2细胞生长曲线比较,加了脂质体的Hep-2细胞的生长曲线呈明显下降趋势,说明大黄素脂质体对Hep-2细胞的生长存在抑制作用.     

反相高效液相色谱法测定大黄药材中游离及结合型蒽醌类衍生物的含量

建立了同时测定大黄药材中蒽醌类衍生物含量的RP HPLC法。色谱柱为HypersilC1 8柱 (2 5 0mm×4 6mmi.d .,1 0 μm) ,流动相为甲醇 乙腈 水 (3∶5∶2 ,磷酸调pH 2 .8) ,流速为 1 .0mL min ,柱温为 2 5℃ ,检测波长为 2 2 5nm。在此色谱条件下 ,各组分在 2 0min内均得到良好分离。平均回收率为 98.83 %～ 1 0 0 .9% ;相对标准偏差 0 .68%～ 1 .5 8%。     

分光光度法测定大黄中大黄素的含量

建立了10倍量90%乙醇回流提取、15倍量乙酸乙脂二次回流提取,最后用碱提酸沉法制备高纯度大黄素的方法。用改进的分光光度法对纯化后产品进行测定,大黄素含量达85.41%。显色剂为5mol/L的NaOH溶液,检测波长为530nm,该显色体系的线性范围为1~400μg/mL,相关系数为0.9993,平均回收率为99.57%,RSD为1.31%(n=4)。